GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ever Supreme Bio Technology Co Ltd (ROCO:6712) » Definitions » Gross-Profit-to-Asset %

Ever Supreme Bio Technology Co (ROCO:6712) Gross-Profit-to-Asset % : 24.37% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Ever Supreme Bio Technology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ever Supreme Bio Technology Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$508.1 Mil. Ever Supreme Bio Technology Co's average Total Assets over the quarter that ended in Mar. 2025 was NT$2,085.0 Mil. Therefore, Ever Supreme Bio Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 24.37%.


Ever Supreme Bio Technology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Ever Supreme Bio Technology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ever Supreme Bio Technology Co Gross-Profit-to-Asset % Chart

Ever Supreme Bio Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only -2.03 17.04 20.75 23.94 31.34

Ever Supreme Bio Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.12 23.63 38.48 47.71 24.37

Competitive Comparison of Ever Supreme Bio Technology Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Ever Supreme Bio Technology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ever Supreme Bio Technology Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ever Supreme Bio Technology Co's Gross-Profit-to-Asset % falls into.


;
;

Ever Supreme Bio Technology Co Gross-Profit-to-Asset % Calculation

Ever Supreme Bio Technology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=660.04/( (2075.92+2136.096)/ 2 )
=660.04/2106.008
=31.34 %

Ever Supreme Bio Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=508.092/( (2136.096+2033.831)/ 2 )
=508.092/2084.9635
=24.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Ever Supreme Bio Technology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ever Supreme Bio Technology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ever Supreme Bio Technology Co Business Description

Traded in Other Exchanges
N/A
Address
Keya Road, 4th Floor, No. 30, Daya District, Taichung, TWN
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the cell preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.

Ever Supreme Bio Technology Co Headlines

No Headlines